NLM Logo

zanolimumab MeSH Supplementary Concept Data 2026


MeSH Supplementary
zanolimumab
Unique ID
C520522
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C520522
Entry Term(s)
MDX-016
humax-CD4
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
HG3L8885M0
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
16
Note
a human monoclonal antibody targeted against CD4 for the potential treatment of cutaneous and noncutaneous T-cell lymphomas
Source
Curr Opin Mol Ther 2007 Apr;9(2):197-203
Date Introduced
2007/06/20
Last Updated
2019/11/01
zanolimumab Preferred
MDX-016 Narrower
humax-CD4 Narrower
page delivered in 0.004s